Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease?

被引:33
作者
Rodrigues, A. F.
Johnson, T.
Davies, P.
Murphy, M. S.
机构
[1] Univ Birmingham, Inst Child Hlth, Clin Res Block, Birmingham B4 6NH, W Midlands, England
[2] Birmingham Childrens Hosp NHS Trust, Stat Advisory Serv, Birmingham, W Midlands, England
[3] Birmingham Childrens Hosp NHS Trust, Dept Dietet, Birmingham, W Midlands, England
[4] Birmingham Childrens Hosp NHS Trust, Dept Paediat Gastroenterol, Birmingham, W Midlands, England
关键词
D O I
10.1136/adc.2006.103416
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Active Crohn's disease can be treated using liquid diet therapy (LDT), but non-adherence may limit success, necessitating corticosteroid therapy. Whole-protein polymeric formula (PF) seems to be much more palatable than amino acid-based elemental formula (EF) and thus may significantly improve adherence to LDT. Aim: To compare adherence to LDT using PF versus EF. Methods: Success in completing a 6-week course of LDT, need for nasogastric tube administration of formula and use of LDT for relapses were compared between children presenting with active disease and treated with EF (n = 53) and children given PF (n = 45). Results: Remission rates were similar (EF 64%, 95% CI 51 to 77 vs PF 51%, 95% CI 37 to 66; p>0.15). 72% (95% CI 60 to 84) given EF completed the initial course of LDT compared with 58% (95% CI 44 to 72) given PF (p = 0.15). Of those failing to complete the initial course, 13% on EF and 16% on PF gave up by choice (non-adherence), the remainder stopping due to treatment failure. Nasogastric administration was more frequent with EF (55%, 95% CI 42 to 68) compared to PF (31%, 95% CI 17 to 45) (p = 0.02). Among those treated successfully at first presentation, LDT was used for 28% of relapses in the EF group (95% CI 12 to 44) and 39% in the PF group (95% CI 19 to 59) (p>0.2) over the next year. Conclusion: PF did not effect adherence to LDT but was associated with significantly reduced need for nasogastric tube administration of formula.
引用
收藏
页码:767 / 770
页数:4
相关论文
共 21 条
[1]  
[Anonymous], 2001, COCHRANE DB SYST REV
[2]  
BEATTIE RM, 1994, ALIMENT PHARM THERAP, V8, P609
[3]  
Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1
[4]   HOW EFFECTIVE IS ENTERAL NUTRITION IN INDUCING CLINICAL REMISSION IN ACTIVE CROHNS-DISEASE - A METAANALYSIS OF THE RANDOMIZED CLINICAL [J].
FERNANDEZBANARES, F ;
CABRE, E ;
ESTEVECOMAS, M ;
GASSULL, MA .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1995, 19 (05) :356-364
[5]   Review article: Crohn's disease - the role of nutritional therapy [J].
Forbes, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 :48-52
[6]   METAANALYSIS OF ENTERAL NUTRITION AS A PRIMARY-TREATMENT OF ACTIVE CROHNS-DISEASE [J].
GRIFFITHS, AM ;
OHLSSON, A ;
SHERMAN, PM ;
SUTHERLAND, LR .
GASTROENTEROLOGY, 1995, 108 (04) :1056-1067
[7]   Enteral nutrition: The neglected primary therapy of active Crohn's disease [J].
Griffiths, AM .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 31 (01) :3-5
[8]   Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children [J].
Heuschkel, RB ;
Menache, CC ;
Megerian, JT ;
Baird, AE .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 31 (01) :8-15
[9]  
JEWELL DP, 1989, GASTROENTEROL CLIN N, V18, P21
[10]   Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial [J].
Ludvigsson, JF ;
Krantz, M ;
Bodin, L ;
Stenhammar, L ;
Lindquist, B .
ACTA PAEDIATRICA, 2004, 93 (03) :327-335